Thanks ct808! This helps clear up some of the picture and that total of 16.2 million shares to clear up those loan accounts could actually be ok. With good news the PPS should be significantly higher than the value you will receive. Thanks again for sharing.
WOW.. another thing this tells me is Charles Cotropia would have NEVER had offered that , UNLESS he had the Preferred Shares to say that. HUGE. -- That CONTROL BLOCK TRANSFER OF SHARES is/OR/ has been completed . Charles could not have said that unless he was in CONTROL of those shares by being Legally Transferred. -- Hence CHANGE OF CONTROL (will be out very quickly now) -- https://backend.otcmarkets.com/otcapi/company/financial-report/265788/content -- Quote "Business Combination Agreement with Bioclonetics Immunotherapeutics, Inc. Resulting in Change of Control - On November 30, 2020, Enzolytics, Inc. (the “Company”) entered into a Business Combination Agreement with Bioclonetics Immunotherapeutics, Inc., (“Bioclonetics”) a Texas Corporation controlled by Charles S. Cotropia, the Company’s current Chief Executive Officer. * As consideration for the Business Combination, and in exchange for 100% of the issued and outstanding stock of BioClonetics, the Company has agreed to issue a total of 204,430,000 newly issued shares of Series B Preferred Stock to Charles S. Cotropia, and others Bioclonetics Designees and 90,570,000 shares of newly issued Series B Preferred Stock to Harry Zhabilov, the Company’s current Chief Financial Officer. Control Block Transfer Agreement * In addition, on November 30, 2020, the Zhabilov Trust, the Company’s Controlling Shareholder, entered into a Control Block Transfer Agreement, under which the Zhabilov Trust has agreed to transfer 35,100,000 shares of Series A Preferred Stock and 231,000,000 shares of Common Stock (together the “Control Block”) to Charles S. Cotropia and other Bioclonetics Designees. * Once such share issuances and transfers are completed, Charles S. Cotropia will be the Company’s new Control Block holder and majority shareholder, in addition to his role as Chief Executive Officer of Enzolytics, Inc., resulting in a Change of Control --- Somehow I am hearing the old Xmas Favorite. " It's Beginning to look a lot like CHRISTMAS" in my mind now .. GLTA
EVERYBODY NEEDS TO REVIEW ct808s posts. Basically you will see that the co is concerned with previous share holders of BCLS and keeps its promises to its shareholders.
Thank you ct808 for revealing this to all of us....even the dogs on this board.
ct808... thank you for sharing. If we get to $1+ by end of next year as I suspect we will, then still turns out to be a pretty nice deal. Let’s hope for all of us!
Market Data 
Markets 
AI
